|
HY-132850-25mg
|
MedChemexpress LLC
|
Dazcapistat [CAS 2221010-42-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-132850-5mg
|
MedChemexpress LLC
|
Dazcapistat [CAS 2221010-42-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-132850-50mg
|
MedChemexpress LLC
|
Dazcapistat [CAS 2221010-42-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-132850-1mL
|
MedChemexpress LLC
|
Dazcapistat [CAS 2221010-42-8] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-153102-100mg
|
MedChemexpress LLC
|
G3-CNP [CAS 118291-90-0]
|
|
|
|
|
HY-153102-25mg
|
MedChemexpress LLC
|
G3-CNP [CAS 118291-90-0]
|
|
|
|
|
HY-P70384-10ug
|
MedChemexpress LLC
|
GFRA1/GDNFR-Alpha-1, Human (410a.a, HEK293, His)
|
|
|
|
|
HY-P70384-50ug
|
MedChemexpress LLC
|
GFRA1/GDNFR-Alpha-1, Human (410a.a, HEK293, His)
|
|
|
|
|
HY-131019-5mg
|
MedChemexpress LLC
|
JF-NP-26 [CAS 2341841-03-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-133532-5mg
|
MedChemexpress LLC
|
PB succiniMidyl ester [CAS 215868-33-0]
|
|
|
|
|
HY-P71781-10ug
|
MedChemexpress LLC
|
SAG, Human (P.pastoris, His)
|
|
|
|
|
HY-P71781-5ug
|
MedChemexpress LLC
|
SAG, Human (P.pastoris, His)
|
|
|
|
|
HY-P71781-50ug
|
MedChemexpress LLC
|
SAG, Human (P.pastoris, His)
|
|
|
|
|
HY-D1809-50uL
|
MedChemexpress LLC
|
Vari Fluor 405-Streptavidin
|
|
|
|
|
HY-D1809-500uL
|
MedChemexpress LLC
|
Vari Fluor 405-Streptavidin
|
|
|
|
|
HY-W008981-1g
|
MedChemexpress LLC
|
Z-Lys(Z)-OH [CAS 405-39-0]
|
|
|
|
|
HY-W008981-5g
|
MedChemexpress LLC
|
Z-Lys(Z)-OH [CAS 405-39-0]
|
|
|
|
|
F621340-2.5g
|
Toronto Research Chemicals
|
4-Fluorophenoxyacetic acid [CAS 405-79-8]
|
|
|
|
|
B410905-100g
|
Toronto Research Chemicals
|
N2,N6-Bis(benzyloxycarbonyl)-L-lysine [CAS 405-39-0]
|
|
|
|
|
B410905-5g
|
Toronto Research Chemicals
|
N2,N6-Bis(benzyloxycarbonyl)-L-lysine [CAS 405-39-0]
|
|
|
|
|
F621340-500mg
|
Toronto Research Chemicals
|
4-Fluorophenoxyacetic acid [CAS 405-79-8]
|
|
|
|
|
F621340-1g
|
Toronto Research Chemicals
|
4-Fluorophenoxyacetic acid [CAS 405-79-8]
|
|
|
|
